These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 25623677)
1. Evaluation of patients' perceptions of mesh usage in female pelvic medicine and reconstructive surgery. Tenggardjaja CF; Moore CK; Vasavada SP; Li J; Goldman HB Urology; 2015 Feb; 85(2):326-31. PubMed ID: 25623677 [TBL] [Abstract][Full Text] [Related]
2. Minimum 1.5-year results of "surgeon-tailored" transvaginal mesh repair for female stress urinary incontinence and pelvic organ prolapse. Önol FF; Tosun F; Güzel R; Boylu U; Küçük EV; Gümüş E Urology; 2012 Aug; 80(2):273-9. PubMed ID: 22857745 [TBL] [Abstract][Full Text] [Related]
3. [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse]. Han JS; Zhang K; Zhu FL; Yao Y; Liang HM; Zhou LF; Guo HY Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):101-4. PubMed ID: 21426766 [TBL] [Abstract][Full Text] [Related]
5. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Younger A; Rac G; Clemens JQ; Kobashi K; Khan A; Nitti V; Jacobs I; Lemack GE; Brown ET; Dmochowski R; Maclachlan L; Mourtzinos A; Ginsberg D; Koski M; Rames R; Rovner E Urology; 2016 May; 91():46-51. PubMed ID: 26845051 [TBL] [Abstract][Full Text] [Related]
6. One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series. Lo TS J Minim Invasive Gynecol; 2010; 17(4):473-9. PubMed ID: 20547113 [TBL] [Abstract][Full Text] [Related]
7. Transvaginal mesh kits--how "serious" are the complications and are they reversible? Lee D; Dillon B; Lemack G; Gomelsky A; Zimmern P Urology; 2013 Jan; 81(1):43-8. PubMed ID: 23200966 [TBL] [Abstract][Full Text] [Related]
8. Pelvic mesh complications in women before and after the 2011 FDA public health notification. Rice NT; Hu Y; Slaughter JC; Ward RM Female Pelvic Med Reconstr Surg; 2013; 19(6):333-8. PubMed ID: 24165446 [TBL] [Abstract][Full Text] [Related]
9. Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update. Koo K; Gormley EA Neurourol Urodyn; 2017 Feb; 36(2):329-332. PubMed ID: 26575470 [TBL] [Abstract][Full Text] [Related]
10. Inaccuracies in News Media Reporting About the 2019 US Food and Drug Administration Ban on Transvaginal Mesh for Pelvic Organ Prolapse Repair. Ray S; Clifton MM; Koo K Urology; 2021 Apr; 150():194-200. PubMed ID: 32439554 [TBL] [Abstract][Full Text] [Related]
11. Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse. Shoureshi PS; Lee W; Kobashi KC; Sajadi KP Int Urogynecol J; 2021 Feb; 32(2):375-379. PubMed ID: 32601782 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Medical Consultation on Patients' Concerns Regarding Vaginal Mesh Use in Pelvic Reconstructive Surgery. Li ALK; Lee PE J Obstet Gynaecol Can; 2019 Feb; 41(2):174-179. PubMed ID: 30482730 [TBL] [Abstract][Full Text] [Related]
13. Transvaginal mesh: a historical review and update of the current state of affairs in the United States. Iyer S; Botros SM Int Urogynecol J; 2017 Apr; 28(4):527-535. PubMed ID: 27549225 [TBL] [Abstract][Full Text] [Related]
14. Defining patients' knowledge and perceptions of vaginal mesh surgery. Brown LK; Fenner DE; Berger MB; Delancey JO; Morgan DM; Patel DA; Schimpf MO Female Pelvic Med Reconstr Surg; 2013; 19(5):282-7. PubMed ID: 23982577 [TBL] [Abstract][Full Text] [Related]
15. Transvaginal mesh surgery for pelvic organ prolapse: one-year outcome analysis. Khandwala S Female Pelvic Med Reconstr Surg; 2013; 19(2):84-9. PubMed ID: 23442505 [TBL] [Abstract][Full Text] [Related]
16. [Transvaginal Prosima mesh and high uterosacral ligament suspension in the treatment of severe pelvic organ prolapsey]. Wang WY; Lu YX; Hu XJ; Liu X; Shen WJ; Liu JX; Ge J; Zhang YH; Zhao Y; Niu K Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):500-4. PubMed ID: 23141159 [TBL] [Abstract][Full Text] [Related]
17. Food and Drug Administration Safety Communication on the Use of Transvaginal Mesh in Pelvic Organ Prolapse Repair Surgery: The Impact of Social Determinants of Health. Mao J; Chughtai B; Ibrahim S; Sedrakyan A Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e133-e138. PubMed ID: 32453208 [TBL] [Abstract][Full Text] [Related]
18. [Impact of vaginal mesh exposure on quality of life in patients undergoing transvaginal reconstructive pelvic surgery with polypropylene mesh]. Zhang YH; Lu YX; Liu X; Shen WJ; Liu JX Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):608-11. PubMed ID: 23141182 [TBL] [Abstract][Full Text] [Related]
19. [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence]. Hu CD; Chen YS; Yi XF; Ding JX; Feng WW; Yao LQ; Huang J; Zhang Y; Hu WG; Zhu ZL; Hua KQ Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):94-100. PubMed ID: 21426765 [TBL] [Abstract][Full Text] [Related]
20. Development of de novo prolapse in untreated vaginal compartments after prolapse repair with and without mesh: a secondary analysis of a randomised controlled trial. Withagen MI; Milani AL; de Leeuw JW; Vierhout ME BJOG; 2012 Feb; 119(3):354-60. PubMed ID: 22239416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]